Witjes JA - Search Results

1

Hexaminolevulinate guided fluorescence cystoscopy reduces recurrence in patients with nonmuscle invasive bladder cancer.

Stenzl A, Burger M, Fradet Y, Mynderse LA, Soloway MS, Witjes JA, Kriegmair M, Karl A, Shen Y, Grossman HB. Stenzl A, et al. Among authors: witjes ja. J Urol. 2010 Nov;184(5):1907-13. doi: 10.1016/j.juro.2010.06.148. Epub 2010 Sep 17. J Urol. 2010. PMID: 20850152 Free PMC article. Clinical Trial.

2

Prognostic factors in superficial bladder cancer. A review.

Witjes JA, Kiemeney LA, Oosterhof GO, Debruyne FM. Witjes JA, et al. Eur Urol. 1992;21(2):89-97. doi: 10.1159/000474811. Eur Urol. 1992. PMID: 1499622 Review. No abstract available.

3

Optimal management of superficial bladder cancer.

Witjes JA, Debruyne FM. Witjes JA, et al. Eur J Cancer. 1991;27(3):330-3. doi: 10.1016/0277-5379(91)90541-k. Eur J Cancer. 1991. PMID: 1827328 Review. No abstract available.

4

Expression of markers for transitional cell carcinoma in normal bladder mucosa of patients with bladder cancer.

Witjes JA, Umbas R, Debruyne FM, Schalken JA. Witjes JA, et al. J Urol. 1995 Dec;154(6):2185-9. J Urol. 1995. PMID: 7500486

5

Risk factors in carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.

van Gils-Gielen RJ, Witjes WP, Caris CT, Debruyne FM, Witjes JA, Oosterhof GO. van Gils-Gielen RJ, et al. Among authors: witjes wp, witjes ja. Urology. 1995 Apr;45(4):581-6. doi: 10.1016/s0090-4295(99)80047-8. Urology. 1995. PMID: 7716838 Clinical Trial.

6

A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder.

Vegt PD, Witjes JA, Witjes WP, Doesburg WH, Debruyne FM, van der Meijden AP. Vegt PD, et al. Among authors: witjes wp, witjes ja. J Urol. 1995 Mar;153(3 Pt 2):929-33. J Urol. 1995. PMID: 7853577 Clinical Trial.

7

Intravesical therapy in superficial bladder cancer.

Witjes JA, Mulders PF, Debruyne FM. Witjes JA, et al. Urology. 1994 Feb;43(2 Suppl):2-5; discussion 6. doi: 10.1016/0090-4295(94)90211-9. Urology. 1994. PMID: 8116130

8

Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group.

Kiemeney LA, Witjes JA, Heijbroek RP, Koper NP, Verbeek AL, Debruyne FM. Kiemeney LA, et al. Among authors: witjes ja. Br J Urol. 1994 Feb;73(2):164-71. doi: 10.1111/j.1464-410x.1994.tb07486.x. Br J Urol. 1994. PMID: 8131019

9

The influence of review pathology on study outcome of a randomized multicentre superficial bladder cancer trial. Members of the Dutch South East Cooperative Urological Group.

Witjes JA, Kiemeney LA, Schaafsma HE, Debruyn FM. Witjes JA, et al. Br J Urol. 1994 Feb;73(2):172-6. doi: 10.1111/j.1464-410x.1994.tb07487.x. Br J Urol. 1994. PMID: 8131020 Clinical Trial.

10

Influence of fibrin clot inhibitors on the efficacy of intravesical Bacillus Calmette-Guérin in the treatment of superficial bladder cancer. The Dutch Southeast Cooperative Urological Group.

Witjes JA, vd Meijden AP, Doesburg W, Debruyne FM. Witjes JA, et al. Eur Urol. 1993;23(3):366-70. doi: 10.1159/000474631. Eur Urol. 1993. PMID: 8508889

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

518 results

Search Page

Filters